BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6778293)

  • 1. Complement and C1q binding substances in otitis media.
    Prellner K; Nilsson NI; Johnson U; Laurell AB
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):129-32. PubMed ID: 6778293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 subcomponents in acute pneumococcal otitis media in children.
    Johnson U; Kamme C; Laurell AB; Nilsson NI
    Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):10-6. PubMed ID: 14475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement aberrations in serum from children with otitis due to S. pneumoniae or H. influenzae.
    Prellner K; Nilsson NI
    Acta Otolaryngol; 1982; 94(3-4):275-82. PubMed ID: 6983204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of C1 subcomponents in chronic urticaria and angioedema.
    Laurell AB; Mårtensson U; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1977; 54(5):434-42. PubMed ID: 885628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1q and C1 subcomponent complexes in otitis-prone and non-otitis-prone children. A prospective study of children during their first years of life.
    Prellner K; Sjöholm AG; Harsten G; Heldrup J; Kalm O; Kornfält R
    Acta Paediatr Scand; 1989 Nov; 78(6):911-7. PubMed ID: 2603719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined IgG2, IgG4 and IgA deficiency: low C1q concentrations and the presence of excess C1r and C1s in an adult patient with recurrent pneumococcal infections.
    Prellner K; Braconier JH; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand C; 1985 Dec; 93(6):257-63. PubMed ID: 2424262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complexes and complement in serous and mucoid otitis media.
    Laurell AB; Nilsson NI; Prellner K
    Acta Otolaryngol; 1980; 90(3-4):290-6. PubMed ID: 7193396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
    Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
    Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1 subcomponent conplexes in normal and pathological sera studied by crossed immunoelectrophoresis.
    Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):455-64. PubMed ID: 998270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 activation and dissociation in disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
    Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
    J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unactivated form of the first component of human complement, C1.
    Gigli I; Porter RR; Sim RB
    Biochem J; 1976 Sep; 157(3):541-8. PubMed ID: 985398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement in pneumococcal infections with varying degrees of severity.
    Prellner K
    Scand J Infect Dis; 1981; 13(4):263-8. PubMed ID: 7313580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
    J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of C1q, factor B, factor D and properdin in healthy children, and the age-related presence of circulating C1r-C1s complexes.
    Prellner K; Sjöholm AG; Truedsson L
    Acta Paediatr Scand; 1987 Nov; 76(6):939-43. PubMed ID: 2827430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.